Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethosuximide and Pentoxifylline for Abdominal Pain in IBS
NCT04217733Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- Nov 2019
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ethosuximide, pentoxifylline in irritable bowel syndrome (IBS), sponsored by Tanta University. Started Nov 2019; status: recruiting.
02
Drugs
ethosuximidepentoxifylline
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT04217733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04217733.